Skip to main content
Fig. 6 | Diabetology & Metabolic Syndrome

Fig. 6

From: Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes

Fig. 6

Representative microphotographs of immunohistochemical staining for α-smooth muscle antigen (SMA) in liver sections and percentage in area of positive immunostaining for α-SMA in the five groups (a, b). Gene expression of fibrosis in the liver of the five groups. Normalized mRNA expression of collagen 1 and 3 (c, d). Data are mean ± SD. *P < 0.05 vs. control; §P < 0.05, ¶P < 0.001 vs. vehicle

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us